Navigation Links
Mast Therapeutics Reports Fourth Quarter And Full Year 2012 Financial Results
Date:3/19/2013

vanced form of atherosclerosis, where we believe the potential to demonstrate a treatment effect is greatest.  Based on the similar pathophysiology of atherosclerotic arterial disease, we believe that clinical proof-of-concept data in acute limb ischemia will increase development and partnering opportunities in other forms of occlusive arterial disease.  We expect to generate clinical proof-of-concept data in a relatively short period of time and with relatively modest investment, which we plan to leverage to find a partner to develop MST-188 in larger market indications within arterial disease, such as stroke." 

Fourth Quarter 2012 Operating Results
The Company's net loss for the fourth quarter of 2012 was $4.0 million, or $0.08 per share (basic and diluted), compared to a net loss of $2.4 million, or $0.06 per share (basic and diluted), for the same period in 2011.

Research and development (R&D) expenses for the fourth quarter of 2012 were $2.1 million, an increase of $0.3 million, or 20%, compared to $1.8 million for the same period in 2011. The net increase was due to increases of $0.3 million in external clinical study fees and expenses and $0.2 million in personnel costs, offset by a $0.2 million decrease in external nonclinical study fees and expenses. The increase in external clinical study fees and expenses was primarily related to an increase in clinical consulting and phase 3 study planning expenses for MST-188.  The increase in personnel costs was primarily related to additional clinical and research-related manufacturing staff hired in 2012.  The decrease in external nonclinical study fees and expenses was primarily related to a decrease in research-related manufacturing activities for ANX-514.

Selling, general and administrative (SG&A) expenses for the fourth quarter of 2012 were $1.8 million, consistent with the same period in 2011.

Year-to-Date Operating Results
The Company's net l
'/>"/>

SOURCE Mast Therapeutics
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Echo Therapeutics Achieves ISO 13485 Certification
2. Orexigen Therapeutics Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2012
3. Echo Therapeutics Appoints Robert Doman to Board of Directors
4. Autoinjectors to 2018 Devices, Therapeutics, Markets, Strategies and Prospect
5. ADVENTRX Completes Name Change To "Mast Therapeutics, Inc."; New Ticker Symbol: "MSTX"
6. Cell Therapeutics to Present at the ROTH Capital Partners 25th Annual Growth Stock Conference
7. PTC Therapeutics Closes $60 Million Private Financing
8. Orexigen Therapeutics to Host Full Year and Fourth Quarter 2012 Financial Results Conference Call and Webcast
9. Sorrento Therapeutics Signs Exclusive Option to Acquire IGDRASOL
10. Todays Research on PDL BioPharma, Dendreon, Medivation, ACADIA Pharma, and Cell Therapeutics
11. Halozyme Therapeutics to Present at the Barclays 2013 Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... NEWPORT NEWS, Virginia , 11. ... führender Hersteller von Kameras für die ... Brust (MBI/BSGI), hat heute die CE-Zulassung ... Mit dem CE-Zeichen kann Dilon das ... seinen Vertriebsbereich auf den Großteil der ...
(Date:7/10/2014)... July 10, 2014  Breg, Inc., a premier ... launched the FreeRunner™ knee brace with new innovations ... patella mal-tracking return to active lifestyles.  FreeRunner,s patent-pending ... braces, providing support when patients need it most, ... don,t. Patellofemoral issues are the most ...
(Date:7/10/2014)... 2014  RESMED INC. (NYSE: RMD ) today ... year ended June 30, 2014 results on Thursday, July 31, ... press release with ResMed,s results will be issued after 1:00 ... webcast to discuss operating results and future outlook. ... US Pacific Time and the live webcast of the call ...
Breaking Medicine Technology:Dilon erhält CE-Zulassung für sein Navigator-Gamma-Sondensystem 2Breg Introduces Knee Brace to Help Runners with Patellofemoral Pain Syndrome 2ResMed To Announce Fourth Quarter And Fiscal Year-End 2014 Results 2
(Date:7/12/2014)... The report, "Phthalic Anhydride and Derivatives (Plasticizers, Unsaturated Polyester ... – Trends & Forecast to 2018," defines and segments ... volume and value. The report also estimates the demand ... phthalic anhydride is projected to grow from an estimated ... with a CAGR of 5.24% from 2013 to 2018. ...
(Date:7/12/2014)... 12, 2014 The Security Analytics market ... to $3,376.6 million by 2019, at an expected CAGR ... The challenges to counter the increasing number of security ... outdated cyber defense systems in organizations are enormous. Vendors ... remodeling their existing architecture to develop better and more ...
(Date:7/12/2014)... increase in the summer as people gather around fire pits, ... vulnerable to these seasonal fire hazards: children. "Young children ... putting their hands on the side of cooking grills," Dr. ... University Medical Center in Maywood, Ill., said in a Loyola ... with fire, you get burned, is true -- you ...
(Date:7/12/2014)... As DePuy Pinnacle hip lawsuits ( ... Bernstein Liebhard LLP notes the publication of a new ... failure of metal-on-metal hip replacements. The research, which appears ... Bone & Joint Surgery, looked at 597 patients ... at least twelve months earlier. The blood metal ion ...
(Date:7/12/2014)... 2014 Doylestown Hospital recently conducted an ... men’s health questions. Paddock tackles topics including main ... women live longer than men, and testosterone replacement therapy, ... Simple featured on Doylestown Hospital’s website, Dr. Brad ... any age. If you notice pain, bulging, or asymmetry ...
Breaking Medicine News(10 mins):Health News:Phthalic Anhydride Market Projected to Reach $8.42 Billion by 2018 – Report by MarketsandMarkets 2Health News:Phthalic Anhydride Market Projected to Reach $8.42 Billion by 2018 – Report by MarketsandMarkets 3Health News:Phthalic Anhydride Market Projected to Reach $8.42 Billion by 2018 – Report by MarketsandMarkets 4Health News:North America Security Analytics Market Worth $1,215.2 Million by 2019 - New Report by MicroMarket Monitor 2Health News:North America Security Analytics Market Worth $1,215.2 Million by 2019 - New Report by MicroMarket Monitor 3Health News:North America Security Analytics Market Worth $1,215.2 Million by 2019 - New Report by MicroMarket Monitor 4Health News:Burn Injuries More Common in Summer 2Health News:DePuy Pinnacle Hip Lawsuit News: Bernstein Liebhard LLP Notes Release of New Study Tying Elevated Metal Ions to Metal-on-Metal Hip Failure 2Health News:DePuy Pinnacle Hip Lawsuit News: Bernstein Liebhard LLP Notes Release of New Study Tying Elevated Metal Ions to Metal-on-Metal Hip Failure 3Health News:DePuy Pinnacle Hip Lawsuit News: Bernstein Liebhard LLP Notes Release of New Study Tying Elevated Metal Ions to Metal-on-Metal Hip Failure 4Health News:Ivyland Medical Center’s Dr. Brad Paddock Offers Tips for Men’s Health 2
... half a million women around the world, including an ... planning methods developed by Georgetown University Medical Centers Institute ... of others use CycleBeads a visual aid developed by ... plan or prevent pregnancy. , Now CycleBeads are ...
... model of Treacher Collins Syndrome (TCS), the Stowers Institutes Trainor ... of craniofacial development either by inactivating a gene implicated in ... The work, which was posted to the Web site of ... teams 2006 discovery of the cellular cause of TCS. ...
... Higher Protein, Fish-based Formula Ideal for Dogs ... The Wellness(R),( http://www.wellnesspetfood.com ) brand of ... the availability of Wellness CORE(TM) Dog Ocean ... CORE Dog line. CORE Ocean delivers a,fish- ...
... Mercury has again been in,the news with the ... sushi by,the New York Times and Oceana/Mercury Policy Project ... 3 pieces of tuna tested had levels,above FDA,s action ... interests,against those covering the news was swift and erroneous. ...
... Company, Inc. (Nasdaq: IPCM ), a leading provider of ... and,Jeffrey Taylor, President and Chief Operating Officer, are scheduled to,present ... Services,Conference in New York, NY., Event: 2008 ... February 11, 2008 Time: 9:00 a.m. ET ...
... it has been common practice to exclude older patients from ... rates. , However, patients such as ... are proving that perhaps age does not always matter. ... that select patients age 65 and older can safely undergo ...
Cached Medicine News:Health News:CycleBeads help women manage their fertility 2Health News:Trainor Lab prevents rare birth defect by inactivating p53 gene 2Health News:Introducing New Wellness(R) CORE(TM) Dog Ocean Formula - The Most Balanced Fish-Based Grain-Free Diet Available 2Health News:Introducing New Wellness(R) CORE(TM) Dog Ocean Formula - The Most Balanced Fish-Based Grain-Free Diet Available 3Health News:Introducing New Wellness(R) CORE(TM) Dog Ocean Formula - The Most Balanced Fish-Based Grain-Free Diet Available 4Health News:Global Consensus on Mercury: Scientists Defend Science Journalists 2Health News:Global Consensus on Mercury: Scientists Defend Science Journalists 3Health News:Global Consensus on Mercury: Scientists Defend Science Journalists 4Health News:IPC The Hospitalist Company, Inc. to Present at the 2008 UBS Global Healthcare Services Conference 2Health News:Study finds good outcomes for older lung transplant patients 2
All metal for storing 5 cm x 5 cm (2 inches x 2 inches) 35 mm color slides. Each is individually crafted of high grade steel and finished with a durable baked enamel finish....
Individually, self-contained, stackable drawers....
Shandon Wooden Slide File Storage Box...
Modular Specimen Filing System has five cells that can hold either slides or tissue cassettes....
Medicine Products: